India Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers
Neuland Laboratories Ltd (BOM:524558) Q2 2025 Earnings Call Highlights: Navigating Revenue Decline with Strategic Growth Initiatives
Despite a drop in revenue, Neuland Laboratories Ltd focuses on strategic expansions and partnerships to drive future growth. Nov 07, 2024
GuruFocus News Drug Manufacturers
Dr Reddy's Laboratories Ltd (RDY) (HY 2025) Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions Propel Future Prospects
Dr Reddy's Laboratories Ltd (RDY) reports robust revenue growth and strategic advancements, despite challenges in North America and increased SG&A expenses. Nov 06, 2024
GuruFocus News Drug Manufacturers
Gland Pharma Ltd (NSE:GLAND) Q2 2025 Earnings Call Highlights: Resilient Base Business Growth Amidst Operational Challenges
Despite a 16% drop in net profit, Gland Pharma Ltd (NSE:GLAND) showcases strong base business performance and strategic collaborations to drive future growth. Nov 05, 2024
GuruFocus News Drug Manufacturers
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q2 2024 Earnings Call Highlights: Revenue Surpasses 1,000 Crore Amidst Mixed Market Conditions
Despite achieving significant revenue growth and improved EBITDA margins, GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) faces challenges in acute segments and pricing pressures. Oct 30, 2024
GuruFocus News Drug Manufacturers
Cipla Ltd (BOM:500087) Half Year 2025 Earnings Call Highlights: Record EBITDA Margin and Robust Consumer Health Growth
Cipla Ltd (BOM:500087) reports its highest ever quarterly EBITDA margin and strong performance in North America and Consumer Health segments, despite challenges in India and supply issues. Oct 30, 2024
GuruFocus News Drug Manufacturers
Sun Pharmaceuticals Industries Ltd (BOM:524715) Q2 FY25 Earnings Call Highlights: Robust Growth in Revenue and Profitability
Sun Pharmaceuticals Industries Ltd (BOM:524715) reports a strong Q2 FY25 with a 10.5% revenue increase and a 28% rise in net profit, despite challenges in emerging markets and ongoing litigation. Oct 29, 2024
GuruFocus News Drug Manufacturers
Hester Biosciences Ltd (BOM:524669) Q2 2025 Earnings Call Highlights: Impressive Growth Across Divisions and Strategic Expansion Plans
Hester Biosciences Ltd (BOM:524669) reports robust growth in product sales and outlines future strategies for its animal and pet care divisions. Oct 29, 2024